Come listen to pitch-structured presentations by successful biomedical start-ups based in Cambridge. These companies are excited to share how they managed to launch a business from a scientific idea and will discuss their background, current project and future directions.
GUEST SPEAKERS: SIMON LAMBDEN, SU METCALFE, ATTILA CSORDAS, PORTIA ASLI
DEPARTMENT OF ENGINEERING, UNIVERSITY OF CAMBRIDGE (7-9 PM)
Dr Simon Lambden is part of the academic intensive care team of the University. He will present his experience in launching and securing funding for his new start-up based on a new treatment for sepsis, a life threatening condition that arises when the body’s response to infection causes injury to its own tissues. He will address the issue of convincing private sector funders to invest in a novel idea.
Su Metcalfe is the founder and CSO of LifNano Therapeutics. LIFNanoRx is a nano-bio-med company focused on treatment of Multiple Sclerosis (MS), an auto-immune inflammatory disease of the central nervous system. Using a critical stem cell factor with unique biological properties alongside nanoparticle technology, they present a new approach to the treatment of MS.
Attila Csordas is the founder AgeCurve, a startup with a vision to provide deep molecular age profiles for every grown-up. They believe that the complexity of ageing can be captured reliably by detecting molecular patterns and analysing big chunks of people’s proteome from saliva, to learn and to assess lifestyle interventions.
Portia Asli is the chief commercial officer of Vocalens, a Cambridge University spin-out startup co-founded by Cambridge engineers and MBAs, developing smart wearable assistive technology for people with visual impairment.